In this study, we demonstrated that PRMT1 catalyzed the methylation of arginine at the R206 of PGK1 protein, and increased ERK-mediated phosphorylation at PGK1-S203, leading to enhanced glycolytic activity and CRC tumorigenesis (Fig. 6R). This evidence concerns the gene PRMT1 and colorectal carcinoma.